Concepedia

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

J M Witkin, James A. Monn, Darryle D. Schoepp, X. Li, C. Overshiner, S.N. Mitchell, G. Carter, B. Johnson, K. Rasmussen, Linda M. Rorick‐Kehn

Journal of Pharmacology and Experimental Therapeutics · 2016 · 106 citations · 52 references

References

52

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Journal of the American Medical Association · 1909 · 7.9K citations · Full text

Medicine, Neurology, Oncology +6

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

A. John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski et al. · American Journal of Psychiatry · 2006 · 5.5K citations

Social Sciences, Psychiatry, Psychology +17

Antidepressant effects of ketamine in depressed patients

Robert Berman, Angela Cappiello, Amit Anand et al. · Biological Psychiatry · 2000 · 3.8K citations

Medicine, Pharmacology, Psychiatry +14

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson et al. · Archives of General Psychiatry · 2006 · 3.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Behavioral despair in mice: a primary screening test for antidepressants.

Porsolt Rd, Aurélie Bertin, M Jalfre · PubMed · 1977 · 3.3K citations

Medicine, Pharmacology, Psychiatry +17